Results 101 to 110 of about 7,735 (172)

Dabigatran (Pradaxa®) [díptic]

open access: yes, 2018
Anticoagulants orals d’acció directa; Dabigatran; MedicamentsAnticoagulantes orales de acción directa; Dabigatran; MedicamentosDirect-acting oral anticoagulants; Dabigatran; MedicinesPreguntes i respostes sobre l’anticoagulant oral d’acció directa ...

core  

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

open access: yes, 2018
Idarucizumab, a humanized monoclonal antibody fragment (Fab), provides rapid and sustained reversal of dabigatran-mediated anticoagulation. Idarucizumab and dabigatran are mainly eliminated via the kidneys.
Markus Honickel   +13 more
core   +1 more source

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

open access: yesJA Clinical Reports
Background It is difficult to evaluate adequate dose of heparin for cardiopulmonary bypass (CPB) by activated clotting time (ACT) in a patient receiving both heparin and dabigatran because dabigatran can also prolong ACT.
Yu Kawada   +4 more
doaj   +1 more source

The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio

open access: yesTherapeutic Advances in Neurological Disorders, 2015
Dabigatran is increasingly being used in clinical practice for the thromboprophylaxis in atrial fibrillation as a convenient therapy that needs no drug level monitoring. However, analysis of the data of the same clinical trial that led to the adoption of
Apostolos Safouris   +3 more
doaj   +1 more source

Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation: An Evidence Based Case Report

open access: yesMajalah Kardiologi Indonesia, 2013
Background. Atrial fibrillation (AF) increases the risk of having stroke as high as five fold. Anticoagulant administration such as vitamin K antagonist has been used regularly to reduce the occurence of stroke.
Alvin Nursalim, Yoga Yuniadi
doaj   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

open access: yesActa Ophthalmologica, Volume 104, Issue 6, Page 674-681, September 2026.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä   +3 more
wiley   +1 more source

Effect of Medication Intake on Dental Implant‐Related Outcomes—A Scoping Review

open access: yesClinical Oral Implants Research, Volume 37, Issue 9, Page 1033-1056, September 2026.
ABSTRACT Objective The objective of this scoping review was to evaluate the effect of systemic medications on dental implant outcomes in medically compromised patients. Material and Methods Electronic and manual searches were conducted for this scoping review.
Alberto Monje   +4 more
wiley   +1 more source

Dabigatran-induced esophagitis

open access: yesCleveland Clinic Journal of Medicine, 2019
The tablets contain tartaric acid, and if they get stuck in the esophagus, the acid leaching out can damage the mucosa.
openaire   +2 more sources

Factors Associated With Surgical Site Infections in Adults Following a Replacement of Weight‐Bearing Joints: A Systematic Review

open access: yesInternational Wound Journal, Volume 23, Issue 9, September 2026.
ABSTRACT Surgical site infection may occur within 90‐days following joint replacement surgery and, in patients undergoing weight‐bearing joint replacement, can complicate recovery and adversely affect quality of life. Although numerous studies have identified factors associated with surgical site infections, synthesised and comprehensive evidence ...
Ut T. Bui   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy